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Abstract
Biorepositories  for  biological  samples have increasingly become very important  in
supporting biomedical research since the 1990s. The Kenya Trypanosomiasis Research
Institute Cryo‐bank for trypanosomes and their vectors was established in the 1970s
with the aim of providing research materials to scientists.  Over 2000 trypanosome
isolates  have  been  collected  and  stored  in  dewars  under  liquid  nitrogen.  Recent
collections  include  tsetse  flies—vectors  of  human  and  animal  trypanosomiasis.
Challenges encountered include distances to remote field sites and impassable roads
and the  cost  of  collection,  preparation,  storage,  and  maintenance  under  resource‐
constrained settings. Under these settings, the challenges can be overcome through
strategic leadership that ensures availability and sustainability of resources, appropriate
institutional  policies,  adoption  of  multidisciplinary  approach  where  appropriate,
working with different  sectors  such as  human health,  livestock,  and wildlife,  and
environmental conservation in order to leverage on capacities in these sectors, and
acknowledging the role of communities from which materials are collected.
Keywords: cryo‐bank, cryopreservation, trypanosomes, stabilates, tsetse flies
1. Introduction
Cryopreservation  is  an  established  practice  of  freezing  and  storing  valuable  biological
materials in liquid nitrogen for long periods of time for use in research, medicine, environ‐
mental studies, and technology development. These materials include parasites, vector tissues,
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and organs, a wide range of human stem cells, plants, microorganisms, etc. Research on these
materials assists in understanding how ecosystems function, how disease transmission takes
place, how human bodies function, and why some vectors of the same species are efficient at
disease transmission whereas others are not able to transmit. Recognizing the importance of
collections of biological materials to research and development and acknowledging the high
cost of field sample collection in terms of financial resources and time, the management of the
Kenya Trypanosomiasis Research Institute (KETRI) has put in place an institutional policy of
continuous collection of trypanosome parasites for cryopreservation. This took advantage of
all field visits undertaken by various scientific research teams to different foci in Kenya, a
country that is endemic for both human and animal trypanosomiasis. This resulted in the
establishment of the KETRI Trypanosome Bank which currently has over 2000 isolates [1] from
various hosts (tsetse flies, human, domestic and wild animals). Some of the recent collections
include vectors of trypanosomiasis, the tsetse flies. Updating of the cryo‐bank with fresh
trypanosome isolates is a continuous process.
Trypanosomes are extracellular protozoan parasites which cause debilitating disease in
humans and animals. In humans, the disease is referred to as human African trypanosomiasis
(HAT) or sleeping sickness, caused by two trypanosome species, Trypanosoma brucei gam‐
biense, responsible for the chronic form of HAT in West and Central Africa, and T. b. rhode‐
siense, which causes acute disease in eastern and southern Africa. The parasites are transmitted
by tsetse flies (Glossina spp.). In animals, the disease is referred to as African animal trypano‐
somiasis (AAT; nagana in cattle, sheep, and goats; surra in camels) and is caused by various
trypanosome species, the major ones being T. vivax, T. congolense and T. evansi [2]. Whereas
majority of the trypanosome species which cause AAT are transmitted by tsetse fly vectors, T.
evansi, is transmitted mechanically by biting flies such as Tabanus spp.; T. vivax has been
reported to be transmitted by both tsetse flies and biting flies [3].
HAT is classified in the category of the most neglected tropical diseases. Current diagnostic
tools have inadequate sensitivity and specificity, thus complicating disease diagnosis and
staging. The drugs available for treatment are highly toxic and not very effective; patients die
if untreated [4, 5]. In 2005, an annual prevalence of 50–70,000 HAT cases/year was reported,
with incidence rates of 15–17,000 cases/year [6]. Although recent data from the World Health
Organization (WHO) shows that the number of reported cases of HAT declined to less than
10,000 in 2009 leading to speculation that the disease could be eliminated [7, 8], there is great
need to maintain vigilance through surveillance and research. This is informed by the fact that
HAT was effectively controlled in the 1960s in many endemic countries; however, the disease
re‐surged due to breakdown in surveillance and control activities (Figure 1). WHO [9] has
developed a roadmap for elimination of HAT by the year 2020, which involves development
of new and better diagnostics and drugs [5, 8]. Cryo‐banks such as the KETRI Trypanosome
Bank will therefore be important in contributing to this strategy in order to ensure that
epidemics do not occur in future; and that dormant foci will be prioritized for elimination. One
of the issues for which answers are sought is what happens in some traditional HAT foci when
the disease is not reported in humans. Some of the new technological advances that are
providing more insights include genetic analysis of both parasite and vector genomes and
Cryopreservation in Eukaryotes4
identification of specific proteins as targets for development of vaccines, new and sensitive
diagnostic tests.
Figure 1. Sleeping sickness as a reemerging disease.
Isolation and cryopreservation of new trypanosome strains from patients in different HAT
foci ensures availability of these stabilates for use in parasitological, biochemical, molecular,
serological and pharmacological investigations many years after their isolation from the host.
Brun et al [2] observed that one of the major obstacles in the elucidation of the factors
responsible for relapses after melarsoprol treatment was the lack of recent T. b. gambiense
isolates from patients from various endemic areas where the problem has been reported. The
WHO steering committee on human African trypanosomiasis treatment has therefore
recommended that collection of stabilates be a continuous activity in order to monitor the
occurrence and spatial distribution of treatment failure [10] and refractoriness of tsetse to
infection. Since its inception, KETRI and now KALRO‐Biotechnology Research Institute
developed an institutional policy of encouraging collection of stabilates by scientists and
clinicians, for cryopreservation. In this chapter, we describe the procedures of isolation and
cryopreservation of trypanosome stabilates for research and development in resource
constrained settings.
2. Field isolation of trypanosomes
Trypanosomes are isolated from infected hosts during active or passive disease surveillance
activities. The infected hosts include humans, domestic and wild animals, as well as tsetse fly
vectors. Parasites are isolated from biological fluids including blood, cerebrospinal fluid (CSF)
and lymph node aspirates, and/or body parts of tsetse fly vectors. Depending on the host
parasitemia and/or density of trypanosomes in the biological fluids at the time of isolation,
trypanosomes can be either cryopreserved directly or propagated in immunosuppressed
laboratory rodents prior to cryopreservation.
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2.1. Diagnosis: buffy coat and whole blood parasitemia
Parasitological diagnosis of trypanosome infections in animals and humans can be made
through microscopic examination of wet blood smears, stained thin and thick blood smears,
smears of lymph node aspirates, and buffy coats [11]. Under normal field conditions when
large numbers of animals are sampled, examination of buffy coats, obtained through capillary
tube centrifugation technique (CTC) [12], is the preferred method of diagnosis due to its higher
sensitivity compared to other microscopic techniques. Animals suspected to be infected with
trypanosomes are bled from the ear vein into heparinized capillary tubes after which the 3/4
full capillary tubes are sealed at one end with plasticine and then spun in a hematocrit
centrifuge at 10,000 revolutions per minute for 5 min. Blood separates into three portions,
namely, the red blood cells, which settle at the bottom of the capillary, the plasma portion found
at the top, and the buffy coat portion, which forms at the interface of the red blood cells and
plasma. Trypanosomes are concentrated in the buffy coat portion of the centrifuged blood,
thus enhancing the sensitivity of the test. In humans, diagnostic methods that are routinely
employed to detect blood trypanosomes include (CTC), quantitative buffy coat (QBC), mini
anion exchange centrifugation technique (mAECT), and modified mAECT [13]. For the
diagnosis of trypanosomes in cerebrospinal fluid, available methods include single and double
centrifugation and modified single centrifugation (MSC), with the MSC being easy to perform
and as sensitive as the double centrifugation [13].
Once confirmed positive, the density of trypanosomes in the relevant biological, fluid is
determined. Whole blood is drawn from the jugular vein of the infected host into anticoagulant
containing tubes and used to quantify the parasitemia using the matching method [14] for the
Trypanozoon group of trypanosomes. Direct isolation is therefore determined by whole blood
parasitaemia.
2.2. Direct isolation of parasites from infected biological fluids
Parasitemia is usually low in naturally infected hosts. However, the required density of
between 3.2 × 107 trypanosomes/ml and 1.3 × 108 trypanosomes/ml may be obtained in a small
proportion of the infected hosts, thus permitting direct cryopreservation of the stabilates. In
such cases, the infected whole blood is mixed with either of the following cryoprotectants and
processed:
1. 20% glycerol in EDTA saline glucose (ESG), pH 8.0 in the ratio of 1:1.
2. Glycerol in the ratio of 1:4, that is, one part of the infected blood to four parts of glycerol.
Samples are then labeled and dipped into a vapor shipper liquid nitrogen cylinder for
transportation from the collection site to the main laboratory for further processing. A vapor
shipper is a liquid nitrogen cylinder which has a mechanism of absorbing liquid nitrogen into
its system leaving the hollow space full of liquid nitrogen vapor, with temperature in the range
of –60 to –80°C. In the laboratory, samples are removed from the vapor shipper and allowed
to thaw on ice or at 4°C after which they are dispensed into plain capillary tubes (Figure 2),
which are then sealed at one end using plasticine.
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Figure 2. Loading plain capillary tubes with cryo‐protected infected blood sample.
Figure 3. Aluminum cane for holding the ampoules.
The loaded and sealed capillary tubes, approximately 18 in number, are then accommodated
in a perforated 4.5 ml ampoule tube into which a label is inserted. The label has the laboratory
sample identification number. The ampoule normally has two perforations, one at the top and
the other at the bottom to allow direct contact of the sample with liquid nitrogen and at the
same time continuous flow of liquid nitrogen from the top through the bottom perforations.
Before permanent storage, a capillary is removed from the suspended sample and the viability
of the trypanosomes confirmed. For ease of permanent storage in liquid nitrogen at –196°C,
the ampoule is then placed on to an aluminum cane which has the capacity of holding at least
two ampoules: one at the top and the other at the bottom of the cane. The cane is then placed
into a canister, with each canister having a capacity of holding 14 canes. The canister is then
immersed into liquid nitrogen in the permanent storage dewar (Figures 3 and 4) at –196°C.
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Figure 4. Stabilate storage dewars.
2.3. Isolation and propagation of low parasitemia blood samples in laboratory rodents
When the parasitaemia in the whole blood of the naturally infected host is low i.e. below
1.3×108 trypanosomes/ml, the anticoagulated infected blood sample is intraperitoneally
inoculated into an immunosuppressed laboratory rodent. It is advisable to inoculate two
rodents, usually mice, per positive blood sample (isolate). This is carried out in the field where
the animals are given identification numbers and transported to the laboratory for monitoring.
In the laboratory, the infected mice are maintained on commercial mice pellets (Unga Feeds
Ltd., Kenya), provided with water ad libitum and monitored for development of parasitemia.
At the first peak of parasitemia between 1.3 × 108 trypanosomes/ml and 2.5 × 108 trypanosomes/
ml, the infected mice are euthanized and the blood harvested by cardiac puncture into tubes
containing EDTA as anticoagulant. The blood is mixed gently before addition of a cryopre‐
servative at a ratio of 1:1. The samples are suspended in liquid nitrogen vapor for at least 2 h
using a cooling jacket before permanent storage in liquid nitrogen at –196°C [15, 16]. Samples
with a trypanosome concentration below 6.3 × 107/ml may also be preserved by direct addition
of glycerol to infected biological fluids to a final concentration of 20%, especially if the isolated
trypanosome species does not infect rodents [17].
3. Cryopreservation
3.1. Cryopreservation media
The most commonly used cryopreservative is 20% glycerol in EDTA saline glucose (ESG).
ESG is first prepared by dissolving 8.00 g NaCl, 0.30 g KH2PO4, 2 g EDTA (disodium or di‐
potassium), and 2 g glucose in 800 ml distilled water, adjusting the pH to 8.0, and then top‐
ping up to 1 liter with deionized/distilled water. Glycerol is then added to the prepared
solution at a ratio of 1:4 to make 20% glycerol in ESG. Recently, Triladyl® (MiniTüB GmbH
and CO. KG, Tiefenbach, Germany), a commercially available culture medium that is tradi‐
tionally used for preserving bull semen, has been found suitable for cryopreservation of try‐
panosomes. Triladyl is most efficient when added to the infected biological fluids/materials
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to a concentration of 40–90% [18, 19]. Triladyl has subsequently been adopted as an alterna‐
tive cryopreservative at the KETRI Trypanosome Bank.
Buffers commonly used in cryopreservation
EDTA saline glucose (ESG) pH 8.0
NaCl 8.00 g
KH2PO4 0.30 g
EDTA (disodium or dipotassium) 2 g
Glucose 2 g
Dissolve in about 800 ml distilled water, top up to 1 l.
Normal saline
Dissolve 8.5 g NaCl in 1 l of distilled water
Phosphate Saline glucose (PSG) pH 8.0
Na2PHO4 5.392 g/l
Na2HPO4 (H2O)12 (hydrous) 13.608 g/l
NaH2PO4 0.239 g/l
NaH2PO4(H2O) hydrous 0.276 g/l
NaH2PO4(H2O)2 hydrous 0.312 g/l
NaCl 1.7 g/l
Glucose 10.00 g
Dissolve in about 800 ml distilled water; top up to 1 l.
3.2. Cryopreservation procedure
Biological materials from infected vertebrate hosts (blood, cerebrospinal fluid (CSF), and
lymph node aspirates) and/or body parts of tsetse fly vectors are processed as previously
described [17, 20, 21]. Briefly, samples with a concentration of more than 6.3 × 107 trypano‐
somes/ml are mixed with a cryopreservative (20% glycerol in ESG or 40–90% Triladyl) at a ratio
of 1:1. The diluted sample is then loaded into an ampoule and wrapped or held in a cooling
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jacket which is suspended into the vapor space of a liquid nitrogen shipper (temperature range
of –60 to –80°C) for transportation to the laboratory. Samples from infected humans or animals
with parasite counts below 6.3 × 107 trypanosomes/ml (equivalent to antilog 7.8) [14], or
suspects with a low packed cell volume (usually <25%) are inoculated into laboratory rodents
for amplification/propagation [19]. The rodents may be immunosuppressed using either
cyclophosphamide at 100 mg/kg daily for three consecutive days or by gamma‐irradiation at
600 rads (6 gray) for 6 min before the inoculation [22, 15]. Swiss white mice are preferred for
propagation of most species of trypanosomes, while Mastomys natalensis are preferred for T.
b. gambiense [23]. Inoculated rodents are sacrificed at the first peak of parasitemia and the blood
harvested by cardiac puncture into tubes with EDTA as anticoagulant. The blood is mixed
gently before addition of a cryopreservative at a ratio of 1:1. The diluted samples are then
suspended in liquid nitrogen vapor for at least 2 h before being stored permanently in liquid
nitrogen at –196°C [24, 25].
Essential requirements for cryopreservation
1. Immunosuppressed mice
2. Mice pellets
3. Sawdust
4. Disposable 1 ml syringes and needles gauge 26
5. Trypanosomes either from the cryo‐bank or from infected hosts (humans/animals) or tsetse flies
6. Glycerol
7. Cotton wool
8. Tissue paper
9. Capillary tubes (plain)
10. Plasticine
11. 4.5 ml plastic ampoules
12. Liquid nitrogen
13. Cooling jacket
The following information is collected and recorded:
1. Host of isolation
2. Locality (georeferenced) and year of isolation
3. Scientist who did the isolation
4. Number of passages the trypanosomes has undergone before cryopreservation
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5. The prepatent period of the infected mice after each passage, if several passages have been done
6. The duration of infection in the infected mice between the time of inoculation and sacrifice of the
mouse for cryopreservation
7. Species of trypanosome
8. Physical location of the sample in the cryo‐bank
In event of cryopreservation from the natural host:
• The suspected infected blood sample is injected into immunosuppressed mice
• The infected mice are monitored for development of parasitemia
• Cryopreservation carried out as outlined above
At the KETRI trypanosome cryo‐bank, the first parasite population isolated from the field is
the original or primary isolate. If the parasite numbers are high, the primary isolate is cryo‐
preserved as original field isolate; however, in order to sustain/maintain the original cryopre‐
served sample and to produce adequate material for research, the original isolate is expanded
in the appropriate animal model and cryopreserved as a derivative of the original sample, but
with a different bank reference number from the first passage number. Subsequent passages
or derivatives of the same are given different reference numbers in order to monitor the use
and performance of the particular isolates. Clones may be prepared either from the primary
or subsequent passages or both. All these events are monitored and recorded for future
reference and when issuing materials for research.
3.3. Preparation of the cryopreserved sample for the infection of laboratory animals
Following receipt of the duly signed and approved request form from the scientist, the person
incharge of issuance of cryopreserved material records the physical position of the sample in
the cryo‐bank. The sample is retrieved from its position, the ampoule cork opened; and using
a pair of forceps, the reference number is confirmed. One capillary is removed and transferred
into an ampoule placed on ice for thawing. The remaining stabilate is returned into its position
in the bank before it thaws.
The procedure for infection of laboratory animals
1. Use 1 ml syringe and 26‐gauge needle
2. Fill the syringe with phosphate saline glucose (PSG) pH 8.0 up to 0.2 ml
3. Using a diamond pencil cut the sealed end of the capillary tube containing the trypanosome stabilate
4. Insert the needle into the capillary and suck the contents
Isolation and Cryopreservation of Trypanosomes and their Vectors for Research and Development in Resource...
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5. Pull the piston and mix the contents with the PSG buffer thoroughly
6. Remove the air bubbles and place a drop of the mixture on the microscope slide, cover with a cover
slip, and examine the parasitemia at 400 × magnification
7. Infect the experimental (donors) as required by the protocol
Precaution:
1. Use of protective devices while handling cryopreserved samples is mandatory. This is necessary
because the samples being handled contain live parasites, some of which are pathogenic to humans.
Also, nitrogen at –196°C burns. Industrial gloves are recommended while handling liquid nitrogen.
Use of facial masks will protect the user from harmful effect in case of contact with the eyes. All safety
precautions should be strictly observed when capillary tubes are withdrawn from the liquid nitrogen;
they sometimes burst before they are transferred into the screw capped ampoules to thaw, possibly
due to differences in temperature.
2. It is recommended that retrieval of the sample should be rapid to avoid the thawing of the remaining
samples.
4. Cloning of trypanosomes
Cloning of trypanosomes is necessary for the production of a homogeneous population of
trypanosomes. It is carried out as previously described by Otieno and Darji [23]. Briefly, a
sample containing trypanosomes is diluted in PSG pH 8.0, to 1 trypanosome per micro‐
scopic field at 400× magnification. This is followed by addition of 0.5 ml guinea pig se‐
rum. Using a needle, a drop of the trypanosome suspension is placed on a cover slip that
is overturned onto a cavity slide moistened with PSG to prevent evaporation of the drop.
In the laboratory, the drop is examined under a microscope (400× magnification) by at
least three experienced technicians to confirm the presence of a single and viable trypano‐
some, which is aspirated and inoculated into an immunosuppressed Swiss white mouse.
Inoculated mice are monitored for parasitemia development and sacrificed at the first
peak of parasitemia. Blood is harvested by cardiac puncture for cryopreservation of the
clone of trypanosomes.
5. Maintenance of cryopreserved trypanosomes
5.1. Liquid nitrogen
Cryopreserved trypanosomes are permanently stored in liquid nitrogen. The samples must
always be fully immersed in liquid nitrogen and the levels maintained by frequently refilling
the storage Dewars. The refilling period is determined by the frequency at which the Dewars
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are opened during issue of materials for research. The more frequent they are opened, the more
liquid nitrogen vapor is lost, hence the need to refill. Under normal circumstances, refilling is
done fortnightly.
5.2. Trypanosomes viability and infectivity tests
It is important to ascertain that the cryopreserved samples remain viable by randomly test‐
ing the infectivity of the parasites in laboratory rodents to ensure that this has been main‐
tained and not lost over long periods of storage. The viability testing is performed by
removing a single capillary of each of the cryopreserved trypanosome isolate, thawing at
room temperature, cutting the sealed end of the capillary tube using a diamond pencil, de‐
canting the capillary contents on a microscope slide, covering the content with a glass cover‐
slips, and examining for the motility of the trypanosomes under the microscope at 400×
magnification.
6. Morphological characterization of trypanosomes
Morphological features assist in the preliminary identification of trypanosomes in the field
after isolation in order to ascertain the species of trypanosomes isolated. This is done through
microscopic examination. Different trypanosome species fall into the following groups,
depending on the morphological features: Trypanozoon, Duttonella, or Nannomonas
(Table 1).
Species Morphology Free flagellum Undulating mem‐
brane
Kinetoplast Other characteristics
T. vivax Monomorphic Present Slightly developed Large rounded terminal Very motile, posterior end
rounded
T. uniforme  Monomorphic Present Slightly developed Large rounded terminal Very motile, posterior end
rounded
T. congolense  Pleomorphic Absent Slightly developed Marginal or central sub‐
terminal
Posterior end rounded or flat
T. simae Pleomorphic Absent Moderately devel‐
oped
Marginal or central sub‐
terminal
More long forms than short forms
T. brucei Pleomorphic Present in long
and intermedi‐
ate forms, ab‐
sent in short
forms
Well developed  Small subterminal  Posterior end: Long forms—point‐
ed Short forms—rounded Inter‐
mediate forms—blunt
T. evansi Basically mono‐
morphic
Present Well developed  Small subterminal  Posterior end rounded or
truncated
T. suis Monomorphic Present Well developed  Small, subterminal, mar‐
ginal
Only infects suids
T. theileri Monomorphic Present Well developed Large, rounded, marginal Posterior end tapering
Table 1. Morphological characteristics of trypanosomes.
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6.1. Some of the trypanosome species distinguishing morphological characteristics include:
• Size and shape of the body
• Position of the nucleus and kinetoplast
• Presence or absence of free flagellum
• The shape of the posterior end which is pointed either sharply, oval, or blunt
The morphological features of the Trypanozoon, Duttonella, and Nannomonas species of
trypanosomes are as shown in Figures 5–7.
Figure 5. Morphological distinguishing features associated with Trypanozoon.
Figure 6. Morphological distinguishing features associated with Duttonella.
Cryopreservation in Eukaryotes14
Figure 7. Morphological distinguishing features associated with Nannomonas.
6.1.1. Trypanosoma brucei gambiense (Trypanozoon) subgroup
Morphological distinguishing features associated with Trypanozoon include:
• Position of kinetoplast—subterminal
• Size of kinetoplast—small
• Posterior end—blunt
• Free flagellum—present
6.1.2. Trypanosoma vivax (Duttonella) subgroup
Distinguishing features include: rounded posterior end, free flagellum, and a large almost
terminal kinetoplast. This group of parasites lack undulating membrane.
6.1.3. Trypanosoma simiae in the same group with T. congolense (Nannomonas)
Distinguishing features include: shape of posterior end—rounded; position of kinetoplast —
marginal; size of kinetoplast—medium; no undulating membrane and free flagellum—
present.
6.1.4. Other methods employed in the laboratory to characterize trypanosomes
• Tsetse transmission studies
Trypanosoma evansi is not transmitted by Glossina but by biting flies.
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• Tissue culture
Trypanosoma evansi does not transform into procyclics in culture.
• Molecular biology studies:
◦ DNA and RNA extraction and analysis
◦ Genetics and functional genomic studies
• In vivo studies using various animals models to characterize virulent phenotypes and drug
resistance. It is important to note that some trypanosome species such as Trypanosoma vivax
do not grow in rodents.
7. Documentation
Over the years of existence of the KETRI Cryo‐bank, the cryopreserved materials were
documented manually on specially designed record sheets known as Kalamazoo and later
electronically. Whichever method is used, the information in the records should include, but
not limited to the following, for the ease of retrieval:
• The host of isolation, age and sex
• Date of isolation
• Isolating scientist
• Suspected species of trypanosome (based on host of isolation and trypanosome
morphology)
• Locality of isolation
• Method of cryopreservation whether direct or after propagation in laboratory animals
• If by propagation in laboratory rodents, the species of rodent used
• The prepatent period, i.e., period between inoculation of the whole blood and first appear‐
ance of trypanosomes in the mouse
• Duration of infection before cryopreservation, i.e., the period between inoculation and the
sacrifice of the animal to harvest trypanosomes for cryopreservation
• In the event where several passages have been made, the passage numbers must be indicated
as well as the species of rodents used at every passage. In addition, the pre‐patent period
and duration of infection must be stated at each passage.
• Physical location of the stabilate in the cryo‐bank
• Work carried out and publications resulting from the use of stabilates
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7.1. Electronic database
The database was developed using Microsoft Access 2000 (Microsoft, USA) relational database.
Hosts of isolation and countries are coded following the International Organization for
Standardization (ISO) protocol [26] (Lumsden, 1978). Primary isolates are, for example,
designated MHOM/KE/85/KETRI 128, where M represents mammal; HOM represents human;
KE indicates the country of isolation, in this case Kenya; 85 is the year of isolation (1985) while
KETRI 128 shows code or reference number of the stabilate. With regard to trypanosome
derived from the previous stabilate usually referred to as derivatives, the number of the
derivative is shown in brackets. For example, MHOM/KE/85/KETRI 128 [KETRI 300] is a
derivative of MHOM/KE/85/KETRI 128 as described by Lumsden [25].
7.2. Trypanosomes isolated, documented, and cryopreserved at KETRI Cryo‐bank
The number of trypanosomes isolated and cryopreserved at the KETRI Trypanosome Bank are
shown in Figure 8. Tables 2 and 3 show the trypanosome species, year, and country of isolation.
Figure 8. Number of primary trypanosome stabilates collected, preserved, and stored at Kenya [1].
Species of trypanosomes: number and period of isolation
Country Isolate/Year Tbb Tbsubgroup Tbr Tbg T.congolense T.vivax T.evansi T.simiae T.theileri T.lewesi UC Mixed
Kenya No 101 194 274 – 107 166 89 3 – – – 29
Year 1961–2001 1961–2006  1958–2009 – 1961–2008 1969–2009 1968–2003 1970 – – 18 1970–2006
Uganda No 1 238 123 22 82 64 – – 2 8 14 5
Year 1968 1960–1983  1959–2004 1959–2002 1955–1983 1961–1972 – – 1972–1973 1966 14 1955–1971
Tanzania No – 57 7 – 35 – – – – – – 9
Year – 1966–1974  1934,1959–1974
– 1966–1974 – – – – – – 1966–1974
Botswana No – – 2 – – – – – – – – –
Year – – 1960 – – – – – – –
Sudan No – – – 26 – – 2 – – – – –
Year – – – 1982–2003 – – 1973 – – – – –
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Species of trypanosomes: number and period of isolation
Country Isolate/Year Tbb Tbsubgroup Tbr Tbg T.congolense T.vivax T.evansi T.simiae T.theileri T.lewesi UC Mixed
Mozambique No – – 2 – – – – – – – – –
Year – – 1980,1983 – – – – – – – – –
Nigeria No – – – – – 4 – – – – – –
Year – – – – – 1970–1973 – – – – – –
Zambia No – – – – 2 – – – – – – –
Year – – – – 1981 – – – – – – –
NDA No 2 21 8 – 17 5 1 – – – 3 2
Year 1961 – – – 1962–1985 1961 – – – – – 2
Total 104 510 416 48 243 240 92 3 2 8 35 45
Adapted from Murilla et al. [1].
Tbb, Trypanosoma bruceibrucei; Tbr, Trypanosoma bruceirhodesiense; Tbg, Trypanosoma bruceigambiense; UN, unclassified; NDA,
no data available.
Table 2. Primary trypanosome isolates collected from various countries and stored at the Kenya Trypanosomiasis
Research Institute Cryo‐bank
Tbb Tb subgroup Tbr T. congolense T. vivax T. evansi T. theileri T. simiae T. lewesi UC Mixed Total
Cattle 85 247 0 119 137 0 2 0 10 21 621
Goat 0 6 0 6 6 0 0 0 0 0 1 19
Sheep 1 8 1 24 3 0 0 0 0 0 7 44
Pig 1 5 0 0 0 0 0 0 0 0 0 6
Camel 0 3 0 1 2 92 0 0 0 0 0 98
Donkey 0 1 0 1 0 0 0 0 0 3 0 5
Cat 0 0 0 0 0 0 0 0 0 0 2 2
Dog 3 6 0 1 0 0 0 0 0 1 0 11
Wildlife 2 40 3 12 0 0 0 0 0 0 5 62
Lizard 0 0 0 0 0 0 0 0 0 3 0 3
Rat 0 0 0 0 0 0 0 0 8 0 0 8
HNI 1 7 4 2 2 0 0 0 0 2 0 18
Total 93 323 8 166 150 92 2 0 8 19 36 897
Adapted from Murilla et al. [1].
Table 3. Animal hosts from which various trypanosomes were isolated and stored at Kenya Trypanosomiasis Research
Institute Cryo‐bank
8. Issuance of stabilates
Trypanosomes are stored and maintained permanently in liquid nitrogen for use by scientists
in the following areas:
1. The pathogenicity/virulence studies
2. Molecular characterization
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3. Drug sensitivity studies
4. Tsetse fly transmission/vector competence studies, etc.
5. Genetic and genomic studies
6. Research and development of new diagnostic tests, drugs, and vaccines
Stabilates are issued to National and International Research Organizations and Institutions of
higher learning following the laid down institutional guidelines. The following documents are
necessary for issue of materials to be effected:
Issuance of trypanosome stabilates
Procedure
1. Research permit from National Council for Science, Technology and Innovation (NACOSTI, Kenya)
2. Stabilate requisition form plus a permit from Director of Veterinary Services (DVS) for stabilates to
be used in other National and International institutions
3. Materials transfer agreement duly signed
4. Stabilate requisition form with relevant approvals for stabilates to be used only within the institute.
It is important that the receiving scientist be committed to avail the scientific information
resulting from the use of these stabilates. This is necessary for updating the trypanosome bank
database and for future reference.
9. Terminologies commonly associated with cryopreservation (from:
Trypanosomiasis a veterinary perspective Lorne E. Stephen pages 440–441)
Terminologies commonly used with cryopreservation technique
1. Trypanosome species
Assemblages of organisms that can be distinguished from other species by one or more stable
discontinuous morphological characters, e.g., T. congolense, T. vivax, T. brucei are different species.
2. Trypanosome subspecies
Assemblages of organisms within a species that cannot be separated from each other by morpho‐
logical characters but only by other stable characters, e.g., T. b. rhodesiense, T. b. gambiense are
subspecies of T. brucei.
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3. Clone
This is a population that has been developed from a single trypanosome.
4. Line
A laboratory derivative of a stock maintained in different physical conditions, e.g., a species of T.
congolense maintained in mice only is a line of that nature, while when maintained in cattle only is
another line of that nature, etc.
5. Population
The group of trypanosomes present at a given time in a given host or it may consist of a mixture of
several species and subspecies.
6. Primary isolate
This is a stabilate made from a naturally infected host or viable organisms present in a culture or
experimental animals following the introduction of the sample from a naturally infected host.
7. Sample
That part of trypanosome population collected on a unique occasion.
8. Stabilate
A cryopreserved sample of viable trypanosomes.
9. Stock
A population derived by serial passage in vivo or in vitro from a primary isolate.
10. Metacyclics
These are the mammalian infective forms of trypanosomes injected by the tsetse fly. Metacyclic forms
are found at the end of transmission cycle.
11. Procyclics
These are the midgut forms of trypanosomes which are found in cultures.
10. Conclusion
Communicable and noncommunicable diseases, including the neglected tropical diseases,
cause chronic life‐long disability, hinder economic development, and impair childhood
development in resource poor settings in Africa where the diseases are endemic [27, 28].
Control of these diseases could be an efficient way to fight poverty since some of these diseases
can be managed very cost‐effectively using evidence‐based control strategies [26, 29, 30]. HAT
is classified as one of the most neglected tropical diseases that exclusively affects poor
communities in low‐ and middle‐income countries (LMIC), except those areas where tourists
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have been reported to have contracted the disease on tour of the affected areas. Because NTDs
affect mostly the socially vulnerable populations, there are several ethical implications to
consider when planning collection and use of these materials. Detection and treatment of these
diseases poses many challenges since most of them present similar clinical symptoms con‐
comitant with variation in response in the affected individual to treatment, and lack of accurate
diagnostic tests. Medical research to improve health care faces a major problem in the relatively
limited availability of adequately annotated and collected bio‐specimens, primarily due to
absence of bio‐banking facilities and associated infrastructure to interrogate the specimen to
tease out relevant information. This limitation has adversely impacted the pace of scientific
advances and successful exploitation of bio‐specimens. Established functional bio‐banks
would surmount this limitation by providing framework for transfer of bio‐specimens (tissues,
blood, and body fluids) and related health data for research. The KETRI Cryo‐bank holds
significant quantities of samples dating from 1930s to date, which include blood, serum, CSF,
tissues, semen from trypanotolerant animals, and both parasite and vector DNA collections.
This is in addition to the pan African trypanosome isolates of specific biomedical interest (e.g.,
drug resistance and virulence) from human and nonhuman primates, and livestock. There is
therefore great need to collect and store biological materials for research in order to monitor
our ecosystems including new and emerging diseases, generate evidence to inform policy, and
in the development of mitigation strategies. In the area of human and veterinary medicine,
these new and reemerging diseases and conditions have complicated the search for new
remedies for their management in the absence of well collected and cryopreserved biological
specimens.
10.1. The challenges
The countries that are heavy burdened by disease also experience high levels of poverty. This
situation is compounded by new and reemerging diseases and conditions. Climate change has
not only resulted in loss of biodiversity but enabled vectors to infest new areas and change
transmission dynamics. Some parasites have changed host seeking behavior with time,
becoming either more virulent or chronic in nature. Development of drug resistance and
appearance of virulent phenotypes is of great public health concern. Whereas the need exists
to collect and preserve these materials for R&D in order to find solutions to these challenges,
the cost of sample collection from the field is prohibitive. Sites are usually remote with
unpassable roads especially in rainy season when disease transmission is high. Once the
materials have been collected and transported to the laboratory, there are high costs related to
processing, cryopreservation, and maintenance of the cryo‐bank. These are not the usual areas
for investment by our governments due to different priorities. There are also challenges related
to communities from which samples are collected, they are usually not involved in the plans
to collect the materials thereby excluding them in finding solutions to their problems.
10.2. The opportunities
The above challenges have created great opportunities for collection and storage of parasites
and their vectors for use in the development of vaccines, diagnostic tests, and new medicines
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applying recent technological advances. In the recent past, improvements have been made on
the conventional nitrogen freezers through development and adoption of validated methods
including a wide range of stem cells. Many cryopreservation protocols exist for freezing and
storing various biological materials. These need to be reviewed and tailored toward delivering
quality biological materials to our research institutions and products to our clinics. Modalities
for sharing of materials by different institutions need to be developed and made operational
in order not to disadvantage communities from which the materials are collected and the
institutions that have collected, preserved, and maintained these materials in resource‐
constrained settings. The contractual arrangements surrounding areas of the material transfer
agreements should be carefully negotiated. National and international institutions (local and
foreign), should invest in adequate bio‐specimen management, legal and administrative skills,
just as they do for developing scientific skills to facilitate sharing of samples and information
associated with the bio‐specimens.
10.3. Lessons learnt: how to establish and sustain cryobank in a resource‐constrained setting
Collection and cryopreservation of biological materials is critical to research and development
but expensive to collect, process, store, and maintain. Institutional top management leadership
supported by the existing national, regional and international guidelines, rules and regulations
are necessary in providing policy direction and resources [31]. In Kenya, tsetse flies, vectors of
human and animal trypanosomiasis, infest mainly conservation areas and wildlife are carriers
of pathogens, hence there is a need to work closely with the Kenya Wildlife Service. Through
effective collaborations and multidisciplinary approach, it is possible to leverage on all
activities undertaken by collaborating institutions to make collections. From the resource‐
constrained perspective, one does not need state‐of‐the‐art bio‐repository to initiate collec‐
tions. Strategic leadership is the key in spearheading:
1. the development of the appropriate institutional policies
1. to define roles and responsibilities for collaborative arrangements among institutions,
strictly observing existing rules and regulations
2. to ensure that communities from which the materials are collected are not taken
advantage of
3. to facilitate the establishment of relevant multidisciplinary teams that cut across
several sectors, e.g., human health, livestock, and wildlife
4. to ensure proper collection, storage, and maintenance of the materials according to
the legal mandates of participating institutions
5. to ensure equity in sharing of the resources,
2. capacity assessment and development to include human, infrastructure, and financial
across the sectors, and
3. training of field teams in best practices regarding sample collection and processing at field
level [32–34].
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Effective coordination of field teams is critical as many of the areas from where the collec‐
tions are made are remote with no electricity. Due to the rough terrain and impassable
roads, especially during the wet season and when the disease transmission is high, a lot of
liquid nitrogen may be lost. In view of this, it is important to ensure adequate liquid nitro‐
gen is available to last the period of the field trip. This is critical and assures viability of the
parasites from the remote field sites to the laboratories for preparation and permanent stor‐
age.
In conclusion, it is possible for institutions to collect, process, store, and maintain biological
resources according to their legal mandates in resource‐constrained settings. This is only
possible through strategic leadership that recognizes the importance of these biological
materials to the respective countries and communities from which they are collected. And for
organizations requesting for these materials to recognize the efforts and cost of the collection,
storage, and maintenance and follow the national and internationally recognized guidelines,
rules and regulations regarding the sharing of the same.
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